ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE

被引：325

作者：

TODD, PA

HEEL, RC

机构：

来源：

关键词：

D O I：

10.2165/00003495-198631030-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：198 / 248

页数：51

共 281 条

[31] BUNNING P, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1406
[32] COMPARISON IN NORMAL VOLUNTEERS OF 3 CONVERTING ENZYME-INHIBITORS - RHC 3659, MK-421 AND CAPTOPRIL
BURNIER, M
BIOLLAZ, J
BRUNNER, HR
TURINI, GA
GAVRAS, H
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06) : 1550 - 1551
[33] ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, DIURETIC, AND CALCIUM-ANTAGONIST - A NEW TRITHERAPY FOR SEVERE ARTERIAL-HYPERTENSION
CHAMONTIN, B
GUITTARD, J
SALVADOR, M
[J]. JOURNAL OF HYPERTENSION, 1985, 3 (05) : 548 - 548
[34] CHAN PS, 1984, FED PROC, V43, P1346
[35] CHEN DS, 1984, CURR THER RES CLIN E, V35, P253
[36] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL
CHRYSANT, SG
BROWN, RD
KEM, DC
BROWN, JL
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) : 741 - 746
[37] A COMPARATIVE-STUDY OF CAPTOPRIL AND ENALAPRIL IN PATIENTS WITH SEVERE HYPERTENSION
CHRYSANT, SG
BAL, IS
JOHNSON, B
MCPHERSON, M
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (02) : 149 - 151
[38] Clauser E, 1983, J Hypertens Suppl, V1, P37
[39] CLELAND J, 1985, BRIT HEART J, V53, P672
[40] CLELAND JGF, 1985, BRIT J CLIN PHARMACO, V19, pP542